CMS has launched the BALANCE Model, a five-year test to lower costs & expand Medicare access to GLP-1 weight-loss drugs while ...
Some of 2026 changes have prompted significant concern, and experts have warned millions will lose access to health care ...
MedPage Today on MSN
New CMS Demo Aims to Increase Access to GLP-1s Under Medicaid and Part D
The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for ...
The Centers for Medicare & Medicaid Services Dec. 23 introduced a new drug pricing model, BALANCE, for Medicare Part D and ...
CMS issues Medicaid work requirements: most adults must report 80 hours monthly of qualifying activities to keep healthcare ...
Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback